The Swine Flu scare has boosted the stock market values of Big Pharma. Following initial reports from Mexico on the influenza outbreak, the demand for anti-flu drugs has skyrocketed.
The most sought after influenza drugs are Tamiflu and Relenza. Treatment courses by the US government have been released from the national stockpile “to make sure health care providers are ready for any escalation in cases.”
Tamiflu is produced by the Swiss pharmaceutical giant Hoffman-La Roche on behalf of a US based biotech company Gilead Sciences, Inc.
While the drug is produced by Roche, it was developed by Gilead Sciences Inc. which owns the intellectual property rights.
Former Defense Secretary Donald Rumsfeld was one of the major shareholders of Gilead Sciences. In 1997, Rumsfeld was appointed Chairman of Gilead
a position which he held until becoming Secretary of Defence
Rumsfeld’s interests and/or holdings in Gilead following his resignation in 2006 are not known.
clipped from: www.globalresearch.ca 
